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Flagellin subunits are important inducers of host immune responses through activation of TLR5 when extracellular
and the inflammasome if cytosolic. Our previous work demonstrated that systemic immunization of cattle with
flagella generates systemic and mucosal IgA responses. The IgA response in mice is TLR5-dependent and TLR5 can
impact on the general magnitude of the adaptive response. However, due to sequence differences between bovine
and human/murine TLR5 sequences, it is not clear whether bovine TLR5 (bTLR5) is able to stimulate an inflammatory
response following interaction with flagellin. To address this we have examined the innate responses of both human
and bovine cells containing bTLR5 to H7 flagellin from E. coli O157:H7. Both HEK293 (human origin) and embryonic
bovine lung (EBL) cells transfected with bTLR5 responded to addition of H7 flagellin compared to non-transfected
controls. Responses were significantly reduced when mutations were introduced into the TLR5-binding regions of H7
flagellin, including an R90T substitution. In bovine primary macrophages, flagellin-stimulated CXCL8 mRNA and secreted
protein levels were significantly reduced when TLR5 transcript levels were suppressed by specific siRNAs and stimulation
was reduced with the R90T-H7 variant. While these results indicate that the bTLR5 sequence produces a functional
flagellin-recognition receptor, cattle immunized with R90T-H7 flagella also demonstrated systemic IgA responses to the
flagellin in comparison to adjuvant only controls. This presumably either reflects our findings that R90T-H7 still activates
bTLR5, albeit with reduced efficiency compared to WT H7 flagellin, or that other flagellin recognition pathways may
play a role in this mucosal response.Introduction
Flagella have been shown to play a significant role in
bacterial pathogenesis, primarily through their function
as motility organelles, but also as adhesins and as pro-
inflammatory agonists. As a consequence, flagella have
been trialled as vaccine antigens in a number of species
[1-5] and it is evident that flagellins promote specific im-
mune responses and may increase the magnitude of the
response, functioning as an adjuvant for the presentation
of heterologous antigens [6,7]. It has been demonstrated
in cattle that systemic vaccination with H7 flagella leads
to the production of IgA and IgG1 against FliCH7 with* Correspondence: dgally@ed.ac.uk
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[3,8,9]. Toll like receptors (TLRs) are crucial compo-
nents that allow recognition of microbial associated mo-
lecular patterns (MAMPs), including Lipid A of LPS,
lipoteichoic acid, peptidoglycan, certain nucleic acids
and flagellin [10,11]. TLRs are a family of transmem-
brane proteins, each consisting of a Leucine-rich extra-
cellular domain (ectodomain) that recognizes distinct
MAMPs and hence is variable between different TLRs.
Most TLRs form dimers following MAMP binding and
some TLRs can function as heterodimers, for example
TLR2 makes a heterodimer with TLR6 to sense lipotei-
choic acid and a heterodimer with TLR1 to sense lipid-
protein combination [12].
TLR5 recognises the flagellin monomer [13,14] and
they are considered to form a TLR5:flagellin complexl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Bacterial strains used in the study
Strain Source
TUV93-0 ΔfliC Lab stock
TUV93-0 ΔfliC transformed with pEW7 (fliCH7) Lab stock
TUV93-0 ΔfliC fliC transformed with pAT12 This study
TUV93-0 ΔfliC fliC transformed with pAT13 This study
TUV93-0 ΔfliC fliC transformed with pAT14 This study
TUV93-0 ΔfliC fliC transformed with pAT15 This study
TUV93-0 ΔfliC fliC transformed with pAT16 This study
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domain (endodomain) that is relatively conserved be-
tween the different TLRs including the presence of a
toll/interleukin-1 (TIR) region that contains specific
amino acids that are phosphorylated upon MAMP bind-
ing and can then interact with different adaptor proteins
leading to signalling cascades resulting in pro-inflammatory
cytokine release [16,11]. In terms of flagellin, it is evident
that specific residues within the more conserved D1 do-
mains are required for binding to the TLR5 ectodomain,
with the more variable D2 and D3 regions responsible for
the antigenic variability of flagellins [17]. While the D0
and D1 domains of flagellin are relatively conserved, vari-
ation in these regions has been shown to limit innate re-
sponses to flagellin expressed by α and ε Proteobacteria,
including Helicobacter pylori [18,19].
Recent research in mice has indicated that induction
of IgA following systemic immunization with flagellin
from Salmonella enterica serovar Typhimurium is con-
sidered to be dependent on the capacity of monomeric
flagellin to stimulate toll-like receptor 5 (TLR5) signal-
ling in specific intestinal dendritic cells [20]. Another
study in mice has also shown that the magnitude of the re-
sponse to flagellin as an antigen is also TLR5-dependent
[21]. There is 79% amino acid homology between the
bovine (NP_001035591.1) and human (NP_003259.2)
TLR5 sequences. In cattle (Bos taurus), there are specific
changes in both the extracellular domain and the TIR
domain in TLR5 in comparison to other mammalian se-
quences [22]. For example, codon S268 has been posi-
tively selected in the artiodactyl clade [22] and is within
the LRR9 loop region identified by Yoon et al. [17] as
being particularly important in the TLR5 interaction
with the N- and C-terminal helices of the flagellin D1
domain. Variation in the human and murine amino acids
at this site (TLR5 268) has also been shown to at least
partially account for differences between these species in
their interactions with flagellins [23]. With the addition
of further artiodactyla TLR5 sequences we have identi-
fied a further potentially functional change in bovine
TLR5 at position 798 in the TIR region, which in most
species including humans and mice is a tyrosine, but in
cattle and other ruminants is a Phenylalanine. It has
been suggested that Tyr798 plays an important role in
TLR5 signaling as mutation of murine TLR5 Tyr798 to
Leu798 resulted in negligible capacity to signal in re-
sponse to flagellin [23]. Very recent work demonstrated
that bovine TLR5 transfected into HEK293T cells did
not appear to signal. However there was some indication
of P38 phosphorylation in bovine macrophages following
addition of flagella although there was no indication as
to whether this was TLR5-dependent [24]. Taken to-
gether, it is unclear whether TLR5 is functionally im-
portant in the recognition of flagellin in cattle.Nonetheless, systemic immunization in cattle with H7
flagellin induces IgA responses [3,8] in line with similar
murine responses to flagellin that were dependent on
TLR5 [20,21,23]. This might indicate that these bovine
IgA responses are also TLR5-dependent and that bovine
TLR5 is functional despite variation in the ectodomain
and the TIR domain. To test this we have transfected
bovine TLR5 (bTLR5) clones into both human HEK293
and bovine EBL cells and analysed responses following
stimulation with wild type H7 and with flagellins engi-
neered to contain site-specific mutations in the TLR5-
binding domains. We also investigated gene expression
and CXCL8 secretion from bovine peripheral blood
monocyte-derived macrophages following addition of H7
flagellin, with and without siRNA knock-down of bovine
TLR5 expression. Finally, immunization studies were
carried out in cattle comparing stimulation of mucosal
humoral responses following systemic delivery of H7 fla-
gella and a variant with reduced capacity to stimulate
TLR5.
Materials and methods
Flagella expression and purification
H7 flagella or engineered variants were expressed from
E. coli O157 TUV93-0 ΔfliC transformed with pEW7
(wild type fliCH7) or plasmid-encoded site-directed mu-
tants (Table 1). Flagella were purified by shearing for all
the in vitro experiments according to published proce-
dures and by acid de- and re-naturation for the calf
immunization trials [3,8,25]. In brief, one colony was
grown overnight on motility agar at 30 °C. 10 μL agar
plugs from the edge of the motility circle were then in-
oculated overnight in LB broth with ampicillin (100 μg/
mL). The next day this was diluted 1:100 into LB with
ampicillin and 1 mM IPTG added when the culture
reached OD600 = 0.5, and the cultures left to grow at 30 °C
for 4-5 h (OD600 > 2). The bacteria were harvested at
4100 × g at 4 °C for 30 min. The supernatants were dis-
carded and the pellets suspended overnight at 4 °C in 0.9%
NaCl at 4% of the initial culture volume. For acid prepara-
tions the pellets were suspended in PBS at 2% of the initial
culture volume.
Table 2 Primers used for H7-FliC mutagenesis
SDM Orientation Oligonucleotide sequence (5’ – 3’)
L500A/I504A F CCCGCTTGCTGCCGCGGACGACGCAGCC
AGCTCCATCGAC
R GTCGATGGAGCTGGCTGCGTCGTCCGCGG
CAGCAAGCGGG
Q89A F CAACAACAACTTAGCGCGTATTCGTGAAC
R GTTCACGAATACGCGCTAAGTTGTTGTTG
Q89D F CAACAACAACTTAGACCGTATTCGTGAAC
R GTTCACGAATACGGTCTAAGTTGTTGTTG
R90A F CAACAACTTACAGGCTATTCGTGAACTGAC
R GTCAGTTCACGAATAGCCTGTAAGTTGTTG
R90A F CAACAACTTACAGACTATTCGTGAACTGAC
R GTCAGTTCACGAATAGTCTGTAAGTTGTTG
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ring platform until a pH ~ 2 was reached and stirred
for 30 min. The preparations were centrifuged at
5000 × g for 30 min. The supernatants were transferred
and neutralised with 1 M NaOH. The volume of super-
natants was measured and (NH4)2SO4 added to 2.67 M
(35.2 g/100 mL) and left overnight at 4 °C. Then the
preparations were centrifuged at 15 000 × g at 4 °C for
15 min. The supernatants were discarded and pellets
suspended in PBS (2 mL for an original litre of cul-
ture). Flagella preparations were dialysed overnight
three times at 4 °C in at 500-1000 volumes of PBS and
stored at −20 °C.
For sheared flagella preparations, the cultures sus-
pended in a 2% volume of PBS bacterial cultures were
made up to 20 mL in PBS. The cultures were sheared
for 2 min on ice with an IKA T-10 homogeniser (Ultra-
Turrax). The cultures were then centrifuged at 4100 × g
for 15 min. The supernatants were collected and re-
centrifuged. This step was repeated 4 to 5 times until
the supernatants were clear. The cleared supernatants
were centrifuged at 15 000 × g for 10 min to remove any
remaining bacteria. The supernatant from this step were
transferred into fresh tubes and centrifuged at 145 000 × g
at 4 °C for 90 min to pellet the flagella. Flagella pellets
were suspended in 500 μL PBS and stored at −20 °C.
Flagellin concentrations were determined by BCA and
purity by coomassie staining following separation on
SDS-polyacrylamide gels.
LPS removal and monomerization of flagella
The first step to remove LPS involved repeated extrac-
tion in 1% TritonX114. This was added to flagella (1 in
500) in an Eppendorf and rotated overnight at 4 °C. The
mixture was then incubated at 37 °C for 10 min and
centrifuged for 15 min at 13 000 rpm in desktop centri-
fuge at RT. The aqueous phase was collected from
clearly visible Tx114 at bottom of tube. This extraction
was repeated 4 times and the collected flagellin filter-
sterilized and dialyzed to remove any remaining of deter-
gent. The second step was a column clean up using
Pierce® High-Capacity Endotoxin binding resin following
manufacturer’s instructions (Thermo Scientific). Endo-
toxin levels were measured using an EndoLISA kit ac-
cording to manufacturer’s instructions (Hyglos GmbH)
and expressed as endotoxin units (EU) per μg protein.
When required, monomerisation of flagellins was car-
ried out by heating flagella at 70 °C for 15 min followed
by filtration by centrifugation at 5000 × g at 4 °C for 30
min using 100 kDa 4 mL filter units (Millipore) [13].
Site-directed mutagenesis of H7 flagella
L500A/I505A, Q89A, and R90A mutations were selected
based on effects previously demonstrated for SalmonellaFliC [13,18] and Q89D and R90T mutations were se-
lected based on naturally-acquired alleles demonstrated
to reduce activation of TLR5 in Helicobacter pylori [18].
Site directed mutants were made following the manufac-
turer’s protocols (QuikChange, Agilent technologies).
The primers used for these reactions are in Table 2.
Amplified and treated constructs were transformed into
E. coli XL10-Gold Ultra competent bacteria and plated
on LB–ampicillin plates and incubated overnight on 37 °C.
Plasmids were extracted and sequenced (DNA Sequencing
and Bioinformatics - GATC Biotech, Germany). Selection
of required alleles followed sequence analysis using
Lazergene software.Motility assay
TUV93-0 ΔfliC transformed with pEW7 (fliCH7) and al-
tered alleles: pAT12 (Q89A), pAT13 (Q89D), pAT14
(R90A), pAT15 (R90T) and pAT16 (L500A/I504A) (Table 1)
were stab inoculated into the centre of motility agar plates
[18] (0.3% agar, with ampicillin and 1 mM final concentra-
tion of IPTG). The plates were incubated at 30 °C over-
night and then examined for the extent of spread.Cell lines
Embryonic bovine lung (EBL) cells were from laboratory
stocks. The cells were grown at 37 °C in a 5% CO2 and
80% humidity in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (v/v) (FBS, Sigma), 1 U
of penicillin (Invitrogen), 1 μg/mL of streptomycin (Invi-
trogen) and 2 mM L-glutamine (Invitrogen). HEK293 and
HEK blue (PDRIVE5s-mIFN-ß) cells were grown in the
above medium with additions when required zeocin 100
μg/mL (InvivoGen), pUNo1 selection blasticidin 30 μg/
mL (InvivoGen) and Normocin (100 μg/mL) (InvivoGen)
was used as antifungal and mycoplasma agent.
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The human and bovine TLR5 clones were obtained from
InvivoGen. The human clone was supplied in embryonic
kidney cells (HEK293) transfected with pUNo1-hTLR05
(InvivoGen) under control of a hEF1-HTLV promoter.
These cells were also transfected with PDRIVE5s-mIFN-ß
containing SEAP as a reporter for NF-κB transcriptional
activation as the mIFNß promoter has four binding sites
for NF-κB. Cells containing the two plasmids are referred
to as “hHEK blue cells” while those just the SEAP con-
struct are referred to as “Null cells”. Confluent cultured
(HEK blue cells) were used to study the capacity of H7 fla-
gellin to activate hTLR5. The bovine clone was supplied
by InvivoGen in E. coli, and so was purified and trans-
fected into the HEK Null cells. Permanent transfection
was selected by addition of zeocin for the SEAP reporter
plasmid and Blasticidin for the bTLR5 clone.
For transfection of the bovine EBLs, the bTLR5 clone
was sub-cloned into a modified ptGFP1 vector [26].
Briefly, the full-length bTLR5 was amplified using spe-
cific primers encoding bovine TLR5 alongside restriction
enzymes sites XhoI and SacII (bTLR5xsFW: CTCGAG
CAC CATGGGAGACTGCCTTG, bTLR5xsRV: CCGCG
GCTAGGAGATGGTGG). Invivogen bTLR5 plasmid was
used as a template in a 25 μL reaction containing 1 μL of
plasmid, 5 μL of GoTaq colourless reaction buffer, 0.5 μL
of each of the primers at 10 mM, 0.5 μL dNTP (10 mM
each), 0.25 μL of a mix of 10:1 GoTaq DNA polymerase
(5 U/μL) and Pfu DNA polymerase (5 U/mL) (both Pro-
mega, Madison, USA). The PCR product was then gel ex-
tracted using QIAquick Gel Extraction Kit (Qiagen Inc.,
Netherlands) and ligated into pGEM®-T Easy Cloning
Vector (Promega, Madison, USA).
Following transformation into competent XL1-Blue
Competent Cells (Stratagene, Agilent Technologies Div-
ision, USA), cells were grown on LB agar (Sigma Aldrich,
USA) supplemented with X-Gal and 10 mM IPTG. White
colonies were grown overnight in 5 mL of LB medium
with ampicillin (100 μg/mL), in a shaking incubator at
37 °C. Plasmid DNA from 4 independent colonies was
then purified using a QIAprep Plasmid DNA Miniprep kit
(Qiagen Inc., Netherlands) following the manufacturer’s
instructions and sent for sequencing to confirm correct
sequence. The confirmed bTLR5 plasmid and modified
vector ptGFP1 were then digested with XhoI and SacII at
37 °C for 3 h in a 50 μL reaction. Digestion was then puri-
fied with a QIAquick PCR Purification kit (Qiagen Inc.,
Netherlands) and ligated at 4 °C overnight using T4 DNA
ligase (Promega, Madison, USA). Ligated products were
then transformed into competent JM109 cells (Promega,
Madison, USA), and seeded into LB agar + kanamycin (50
μg/mL). Positive colonies were grown overnight in 5 mL
of LB medium with kanamycin in a shaking incubator at
37 °C. Plasmid DNA was purified as above andconcentrations determined by spectrophotometry (Nano-
drop, Labtech International, UK).
EBL cells were incubated in DMEM media supple-
mented with 10% foetal calf serum (FCS, Labtech Inter-
national, UK), 100 U/mL penicillin and 100 mg/mL
streptomycin (P/S, Invitrogen Life Technologies, BV,
Netherlands) and 1% L-Glutamine. Cells were passaged
48 h prior to transfection by electroporation in a
Nucleofector™ 2d Device (Lonza Group Ltd., USA) as
described elsewhere [27]. Briefly approximately 2 μg of
bTLR5-ptGFP1 construct or empty ptGFP1 vector (con-
trol) were used to transfect 106 cells alongside 100 μL
Amaxa Nucleofactor solution V, by running program
T-030. 500 μl of DMEM, 10% FCS, 1% L-Glutamine and
P/S was added to the electrophoresis cuvette and then
transferred into tissue culture flasks or plates. After 24 h,
all media was replaced with fresh media supplemented
with 500 μg/mL of neomycin (G418, Sigma Aldrich, UK).
This was replenished every day to remove dead cells, and
the concentration of neomycin reduced to 250 μg/mL a
week after transfection. Once around 25-50% of the
cells were GFP positive, they were cell sorted using a
FACSAria™ III which generated a culture with >95%
GFP+ cells.
In order to further confirm the presence of bTLR5 in
the transfected cells, a PCR was carried out using cDNA
obtained from EBL cells transfected with bTLR5-ptGFP1
and empty ptGFP1 vector as template. Forward primer
was specific for bTLR5 (bTLR5FW: GTGCCTCGAAGC
CTTCAGTTAT) and reverse primer (bTLR5-ptGFP1-
RV: CTAGCCGCGGCTCTAGATCAT AATCAG) was
designed spanning both bTLR5 and ptGFP1 to ascertain
that the amplified fragment was the transfected bTLR5
and not any endogenous TLR5 which could be naturally
produced by EBL cells. The reactions for the amplifica-
tion of the vector/bTLR5 and the endogenous control
GAPDH (GAPDH-FW: GATGCTGGTGCTGAGTATG
TAGTG and GAPDH-RV: ATCCACAACAGACACGT
TGGGAG) was subjected to an initial denaturation of
2 min at 95 °C, followed by 35 cycles of 95 °C for 30 s,
60 °C for 30 s and 72 °C for 45 s using a 25 μL reaction
as detailed previously. All PCR products were visualised
on a 1% agarose gel containing SYBR® Safe DNA Gel
Stain (Life Technologies, BV, Netherlands).
Bovine monocyte-derived macrophages
Bovine monocyte-derived macrophages (MDM) were gen-
erated as described previously [28,29], except that the
MDM were differentiated for 14 days. In brief, PBMC were
initially cultured for 2 h in RPMI-1640 medium without
serum at 5 × 106 cells/mL, before the medium was replaced
with MDM medium (RPMI-1640 supplemented with 20%
FBS, 4 mM L-glutamine and 50 μM β-mercaptoethanol)
with 100 U/mL Penicillin-Streptomycin. The MDM
Tahoun et al. Veterinary Research  (2015) 46:9 Page 5 of 15medium was replaced on days 4 and 11. On day 14 the ad-
herent cells were rigorously washed with phosphate buff-
ered saline (PBS) and detached with TrypLE Express
(Invitrogen). Flow cytometry, using a mouse anti-bovine
SIRPα antibody directly conjugated with RPE-Cy5 (AbD
Serotec: Cat. No. MCA2041C), confirmed that the MDM
purity exceeded 90% (data not shown). Purified MDM
were resuspended at 3 × 105 cells/mL in MDM medium
without Penicillin-Streptomycin, dispensed into 12 well
plates and cultured for 24 h before transfection of siRNA.
Analysis of NfκB activation using a secreted alkaline
phosphatase reporter
Cells were treated with trypsin and diluted to be 5 × 105
cell per mL. 180 μL/well of the cells were added to 96
well plate and 20 μL of the required flagella concentra-
tion added and incubated with the cells overnight at 37 °C
in a 5% CO2 and 80% humidity. Next day 20 μL of the
culture media was added to 200 μL of a ready-to-use
substrate (Quanti blue) in a 96 well plate format (p7998,
Sigma, St. Louis, MI, USA) for 10 min at RT and the read-
ings made at 650 nm using Promega plate reader.
CXCL8/IL8 determination by ELISA
Cells were treated as above and CXCL8/IL8 levels in the
cell culture supernatants was assessed following capture
with mouse anti-sheep IL-8 and detection with rabbit
anti-sheep IL-8 (AbD Serotec, Raleigh, N.C.) followed by
goat anti-rabbit IgG conjugated to HRP (DAKO) accord-
ing to manufacturer’s instructions. Briefly, ELISA plates
(Thermoelectron 3455) were coated with mouse anti-
sheep CXCL8/IL8 antibody (MCA1660) diluted in car-
bonate coating buffer (50 μL per well). The plates were
sealed and incubated at 4 °C overnight. The plates were
washed 6 times in wash buffer (0.05% Triton in PBS)
and 100 μL/well blocking buffer (3% bovine serum albu-
men in wash buffer) was added and incubated at RT for
1 h. Samples and standards were prepared as appropriate
in dilution buffer (wash buffer + 1% BSA). Plates were
washed 5 times in wash buffer and 50 μL of sample andTable 3 Additional primers used in the study
Gene Accession no.
Toll-like receptor 5 (TLR5) NM_001040501
Interleukin 1B (IL1B) NM_174093
Interleukin/CXCL 8 (IL8/CXCL8) NM_173925
Chromosome alignment NM_001205506
Maintaining phosphoprotein 1
F and R denote forward and reverse primers respectively.standard were added in duplicate to the plates. The
plates were incubated at RT for 1 h. The plates were
then washed 6 times and 50 μL/well of the rabbit anti-
sheep IL-8 antibody (AHP425) diluted in dilution buffer
was added. The plates were then incubated at RT for 1 h.
The plates washed 6 times and 50 μL/well of goat anti-
rabbit-HRP (Dako P0448) diluted 1:1000 in RDB was
added and incubated at RT for 1 h. The plates were wash
6 times and 100 μL OPD substrate (Sigmafast OPD P9187
Sigma-Aldrich) was added per well and incubated for 5-10
min depending on reaction time of the controls and this
varied depending on the room temperature. The reactions
were stopped by addition of 50 μL 2.5 M H2SO4 and
plates were read at 492 nm using a BMG FLUORstar
ELISA reader. The concentration of CXCL8 was deter-
mined according to manufacturer’s instructions using re-
combinant bovine CXCL8 (Kingfisher Biotech, Inc.) to
make the standard curve.
We note that sets of experiments were performed with
EBL cells at different densities and transfection efficien-
cies which, in combination with different flagellin prepa-
rations may account for variation in CXCL8 levels
measured at specific flagellin concentrations between
experiments.
Real time PCR analysis of TLR5 and CXCL8 transcripts
Total RNA was extracted from all MDM samples using
the RNeasy mini kit (Qiagen), including a DNase diges-
tion step, according to the manufacturer’s instructions.
The quality and quantity of the resulting RNA was de-
termined by a Nanodrop spectrophotometer. First strand
cDNA was reverse transcribed from 0.2 μg total RNA
using an oligo(dT) primer and GoScript reverse tran-
scriptase (Promega) according to the manufacturer’s pro-
tocols. The resulting cDNA was diluted 1:20 for RT-qPCR
analysis.
Oligonucleotides were designed for bovine TLR5, IL1β
and CXCL8/IL8 using Primer3 [30] and Netprimer (Bio-
soft International) software (Table 3). The mRNA levels
of each transcript were quantified by qPCR using theOrientation Oligonucleotide sequence (5’ – 3’)
F CGATGCCTATTTGTGCTTCA
R CACCACCCGTCTCTAAGGAA
F TCCGACGAGTTTCTGTGTGA
R TGTGAGAGGAGGTGGAGAGC
F CACATTCCACACCTTTCCAC
R GGCAGACCTCGTTTCCATT
F AGCAGTGACCAAGAGCAGGT
R TCATAGCACGACAGCAACAA
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as described previously [28]. The relative quantities of
mRNA were calculated using the method described by
Pfaffl [31]. The RT-qPCR results for chromosome align-
ment maintaining phosphoprotein 1 (CHAMP1) were
used to calculate differences in the template RNA levels
and thereby standardize the results for the genes of inter-
est. CHAMP1 was previously selected from microarray
and RT-qPCR analyses as a constitutively and moderately
expressed gene in activated bovine monocytes and macro-
phages [28,29].
siRNA knock-down of TLR5
Prior to the experiments reported here, three siRNA du-
plexes specific for bovine TLR5 (RefSeq Accession No.
NM_001040501) were obtained from Sigma-Aldrich and
assessed for their ability to knockdown TLR5 mRNA
levels. The siRNAs TLR5#2 (target sequence CAATTTC
ATCCAATTATCA) and TLR5#3(target sequence CGT
ACAAATACGATGCCUA) were found to consistently
knock-down TLR5 mRNA levels between 24 and 96 h.
The third siRNA TLR5#1 (target sequence GTCTGA
ACCCATTCAGAAA) failed to modulate TLR5 mRNA
levels. In addition, the AllStars negative control siRNA,
which does not share homology with any known mam-
malian gene (Qiagen), was used as a non-target siRNA
control.
The transfection reagent Lipofectamine RNAiMAX
(Invitrogen) has previously been shown to be suitable
for transfecting siRNA into bovine MDM [28]. The
MDM were transfected with siRNA following the manu-
facturer’s protocol, initially generating a mix of 3 μL Li-
pofectamine RNAiMAX and 3 μL 20μM siRNA in 200
μL Opti-MEM I reduced serum medium (Invitrogen).
After 20 min incubation at RT the siRNA/Lipofectamine
RNAiMAX mix was added to MDM in 1 mL MDM
medium, giving a final concentration of 50 μM siRNA.
Additional controls included in each experiment were
MDM treated with Lipofectamine RNAiMAX only (trans-
fection control) and untreated MDM (negative control).
After 24 h the medium was replaced with fresh MDM
medium to remove the residual siRNA/Lipofectamine
RNAiMAX mix.
Immunization of cattle
Immunizations were performed at Moredun Research
Institute (MRI) under Home Office licence 60/3179. Eth-
ical approval was obtained from the MRI Animal Experi-
ments Committee. Two groups of conventionally reared
male Holstein–Friesian calves (n = 6) were immunized
on two separate occasions two weeks apart with either
60 μg of WT-H7 + 5mg Quil A adjuvant (Brenntag
Biosector, Frederikssund, Denmark) or 60 μg R90T-H7
+ 5 mg Quil A adjuvant via the intra-muscular route. Acontrol group (n = 3) was immunized in an identical
manner with adjuvant only. Serum samples were col-
lected at days -1, 7, 21 and 28 relative to the first
immunization. The average age of calves at the time of
the first immunization was 14 ± 3 weeks. Faecal samples
obtained from each calf prior to immunization were
confirmed to be negative for E. coli O157:H7 by immuno-
magnetic separation, performed according to the manu-
facturer’s instructions (Dynabeads® anti-E. coli O157,
Invitrogen).
Measurement of serum immunoglobulin levels
WT-H7 and R90T-H7 specific IgA antibodies were quan-
tified by indirect ELISA as previously described [8] using
LPS-free antigen preparations. Antibody titres were calcu-
lated as follows: the log10 optical density (OD) was plotted
against the log10 sample dilution and regression analysis of
the linear part of the curve allowed the calculation of the
endpoint titre with an OD of 0.1 above the average nega-
tive control value. Inter-plate variation was normalised to
a known positive control sample.
Statistical analyses
Mixed models were used to analyse each experiment.
These models are an extension to ANOVA and take ac-
count of variation occurring both between- and within-
experiments, and of correlations between measurements
repeated over time-points or concentrations. Treatment,
concentration (or time) and the treatment by concentra-
tion (or time) interaction were fitted as fixed effects, and
experiment as a random effect, in each model. Pairwise
comparisons between treatment effects at individual
concentration (or time) levels were made within each
model using t-tests. The variance for these comparisons
was determined by the mixed model, taking into account
the between- and within- experiment variation. Adjust-
ments were made for multiple testing in the statistical
tests. When measurements were not repeated over con-
centration or time, only treatment was fitted as a fixed
effect in the mixed model. Log transformations of the
data were used when necessary to ensure that normality
requirements for the model were satisfied. The analyses
were carried out using the MIXED procedure in the
SAS/STAT(r) software. Further information on mixed
models may be found in Brown and Prescott [32].
Results
Signalling from HEK293 cells transfected with human and
bovine TLR5 clones
The bovine TLR5 (bTLR5) and human TLR5 (hTLR5)
clones were obtained from InvivoGen. As a read-out for
activity of HEK293 cells transfected with these constructs,
the cells also contained a plasmid encoding an NF-κB/AP-
1-inducible secreted alkaline phosphatase (SEAP) reporter
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transfected with just the reporter construct but no TLR5
clones were used as a control (Null cells). Both the bTLR5
and hTLR5 clones activated the NF-kB reporter at levels
significantly higher (p < 0.005) than the Null cells over a
range of H7 flagellin concentrations (0.5-5000 ng/mL,
Figure 1A). There was evidence that hTLR5 was more sen-
sitive than bTLR5 to activation by flagellin at lower con-
centrations (0.05 and 0.5 ng/mL, p = 0.027 and p < 0.001
respectively), but differences in expression levels between
the two constructs cannot be ruled out. There was no sig-
nificant difference in their maximum levels of inductionFigure 1 NF-kB dependent signalling from human and bovine TLR5 c
dependent secreted alkaline phosphatase (SEAP) reporter plasmid alone (N
(hTLR5) or bovine (bTLR5) expression plasmid. SEAP levels were determined
site-directed flagellin mutants. (A) NF-kB dependent SEAP production from
flagellin concentrations. SEAP activity from cells transfected with either TLR
levels of 0.5 ng/mL flagellin or greater (p < 0.005). hTLR5 produced higher S
0.05 and 0.5 ng/mL (p = 0.027 and p < 0.001 respectively). (B) NF-kB depend
with different concentrations of WT-H7 and the indicated flagellin mutants. Th
SEAP production from hTLR5 in HEK293 cells following addition of WT H7 and
experiments in this figure were performed a minimum of three times with at
confidence intervals.above a concentration of 5 ng/mL flagellin. This indicated
that the bTLR5 was capable of signalling through NF-kB
in this human-derived cell background.
Mutational analysis of H7 flagellin
Previous mutational analyses of Salmonella enterica ser-
ovar Typhimurium Phase 1 FliC flagellin has helped de-
fine key amino acids required for TLR5 recognition and
signalling within the TLR5 binding domains in the D1
regions of the flagellin monomer (Figure 2A) [13]. We
mutated amino acid residues based on this previous
work as well as analysis of Helicobacter FlaA and FlaBlones in HEK293 cells. HEK293 cells were transfected with an NF-κB-
ull cells) or with the reporter in combination with either a human TLR5
following addition of different concentrations of WT-H7 flagellin or
bTLR5 and hTLR5 following overnight stimulation with a range of H7
5 construct was significantly higher than the non-transfected control at
EAP activity compared to bTLR5 at two concentrations of flagellin,
ent SEAP production from bTLR5 in HEK293 cells stimulated overnight
e dashed line indicates the response to WT-H7. (C) NF-kB dependent
an R90T variant. Differences of p < 0.001 are indicated by an asterisk. All
least three technical repeats. The data shown are the means and 95%
Figure 2 Site-directed mutagenesis of H7 flagellin to reduce TLR5 signalling. (A) Predicted TLR5-binding regions of H7 flagellin (FliC). Top
panel shows the structure of FliC (Salmonella Typhimurium) from PDB entry 1UCU (R-type straight flagellar filament) and is coloured in UCSF Chimera
according to structural domains as indicated. TLR5 binding residues have been mapped within the D1b regions (dark grey). The bottom panel shows
the FliC-H7 D1b regions which are homologous to those from S. Typhimurium and the 4 residues that have been mutated in this study are shown in
red. Q89 and R90 in the D1b amino terminal regions have the same position in S. Typhimurium, whereas the L500 and I504 in FliC-H7 are equivalent
to I411 and L415 (leucine and isoleucine are interchanged) respectively in S. Typhimurium phase 1 FliC (13). (B) Coomassie-stained SDS-PAGE of WT-H7
and variants. Flagella were purified from E. coli O157 TUV93-0 ΔfliC and total protein concentration adjusted following a BCA assay to 2.5 μg per lane.
The left margin shows the approximate molecular size (kDa). (C) Motility of E. coli O157 expressing altered flagellins. Motility was assessed following
inoculation of E. coli O157 (TUV93-0) ΔfliC containing WT fliCH7 clone (pEW7) and site-directed mutants as indicated. Motility was assessed after
overnight incubation.
Tahoun et al. Veterinary Research  (2015) 46:9 Page 8 of 15which have been shown to have a reduced capacity to
stimulate TLR5 [18] as part of a proposed immune eva-
sion strategy. Five mutations (Figure 2A) were intro-
duced successfully into a clone of fliCH7 on plasmid
pEW7 (Materials and methods). Flagella expression was
analysed in E. coli O157 (TUV93-0) ΔfliC transformed
with the WT fliCH7 or the site-directed mutants. Flagella
were purified from all the mutants by shearing andconcentrations were adjusted based on bicinchoninic
acid assays and then analysed by gel electrophoresis for
purity and relative concentration (Figure 2B). The Q89A,
Q89D, L500A/I504A demonstrated motility on 0.3% agar
following overnight culture, whereas R90A-H7 and
R90T-H7 were non motile (Figure 2C). The different fla-
gellins were tested over a range of concentrations for
their capacity to stimulate NF-kB activity in HEK293
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with the exception of Q89A showed reduced SEAP levels
at flagellin concentrations of 5 ng/mL and 50 ng/mL (p <
0.001). R90T was selected for further work as this could
easily be purified at high levels and showed a markedly
reduced signalling capacity compared to WT-H7. R90T
was then compared against the WT-H7 using the hTLR5
clone in HEK293 cells and analysis demonstrated signifi-
cantly reduced NF-kB dependent SEAP production over
a range of flagellin concentrations (0.005-5 ng/mL, p <
0.001), with approximately 100-fold more mutated flagel-
lin (R90T) required to induce equivalent levels of re-
sponse to the WT monomer at these points on the
response curves (Figure 1C).
Analysis of bovine TLR5 activity in bovine epithelial cells
There are possible complications with using the HEK293
cell background to read out for functionality of bTLR5.
These include that the adaptor signalling pathways are
human not bovine and the possibility of some comple-
menting activity from residual TLR5 activity in the
HEK293 cells [17,33], as our non-transfected cells did
show a level of activation, especially at high flagellin
concentrations (Figure 1A). It was important therefore
to test the activity of the bTLR5 clone in a bovine cell
context. To our knowledge there are two main immor-
talized bovine epithelial cell lines that are currently used
by research community: Mac-T, a bovine mammary epi-
thelial cell line [34] and EBLs, an embryonic bovine
epithelial cell line (supplied by the Leibniz Institute
DSMZ-German Collection of Microorganisms and Cell
Cultures). We use EBLs routinely for bacterial infections
studies so we investigated whether these cells were able
to produce CXCL8 following addition of H7 flagellin.
There was no detectable endogenous TLR5 activity in
these cells as determined by CXCL8 assays 16 h after
addition of up to 10 μg of flagellin (data not shown) and
so they were considered an appropriate background in
which to study the bTLR5 clone. In order to aid detec-
tion and selection of transfected EBLs, the bTLR5 region
was sub-cloned into ptGFP1 (Material and Methods)
allowing detection of transfected cells through expres-
sion of GFP.
EBL cells with and without sub-cloned bTLR5 were
then tested for CXCL8 secretion following addition of
flagellin (0.5 ng/mL - 50 μg/mL). The results indicated
that transfecting these cells with the bTLR5 clone en-
abled them to respond to the addition of flagellin by re-
leasing CXCL8 over a range of flagellin concentrations
(Figure 3A, p < 0.001 compared to control cells). Induc-
tion of CXCL8 by LPS was ruled out in two ways; (1)
the majority of LPS was removed from an H7 flagellin
preparation (Materials and methods) leaving less that
0.05 endotoxin units/μg protein (EU) and this still wasable to promote CXCL8 production to a level equivalent
to the original (LPS high) preparation (Figure 3B). Sec-
ondly, addition of purified LPS (1 EU) alone failed to in-
duce any CXCL8 production from EBLs transfected with
bTLR5 (data not shown).
The site-directed mutations in the TLR5 binding do-
main of FliCH7 were tested at 50 ng/mL on EBL cells
transfected with bTLR5 (Figure 3C). The R90T, R90A
and L500A/I504A constructs all showed significantly re-
duced levels of CXCL8 secretion compared to stimulation
with WT-H7 (p < 0.001). At this flagellin concentration
R90T produced lower levels of CXCL8 than the R90A
construct (Figure 3C, p < 0.001). Of note was the finding
that neither Q89A nor Q89D had any impact on levels of
CXCL8 produced compared to WT-H7 at this flagellin
concentration while this was not the case when these
were tested on the hTLR5 in the HEK293 cells, indica-
tive of different recognition or signalling between the
clones and cell types. The R90T flagellin was compared
with WT-H7 over a range of concentrations on the
bTLR5-EBL cells and shown to induce significantly
lower levels of CXCL8 when 50 ng/mL and 500 ng/mL
flagellin was added (Figure 3D, p < 0.001). At these con-
centrations approximately 10-fold more R90T than WT
was required to induce an equivalent level of CXCL8 re-
lease (Figure 3D).
Analysis of TLR5 responses in bovine primary
macrophages derived from PBMCs
We wanted to determine if CXCL8 responses from bo-
vine peripheral blood monocyte-derived macrophages
(MDMs) exposed to flagellin were TLR5-dependent.
MDMs were derived as described previously ([28,29]
and Materials and methods). To determine the initial re-
sponse of the bMDMs to flagellin, TLR5 and CXCL8
transcript levels were determined at 4 and 24 h by RT-
PCR following addition of 26.5 ng/mL H7 flagellin
(Figure 4A). CXCL8 mRNA levels increased at both
time points relative to the T0 value (p < 0.001) while
TLR5 levels were significantly reduced at 4 h (p <
0.001) while there was no significant difference at 24 h
(p = 0.073, Figure 4A).
In order to assess the requirement of TLR5 for CXCL8
production following flagellin stimulation, three different
siRNAs were tested to try and reduce TLR5 transcript
levels in the bovine MDMs using established methods
[28]. The bovine MDMs were cultured for 48 h follow-
ing siRNA transfection. TLR5 and CXCL8 mRNA levels
are shown at 0 and 24 h following addition of 26.5 ng/
mL flagellin (Figures 4B and 4C). It was evident that two
of the TLR5 siRNAs, #2 & #3, had significantly reduced
levels of TLR5 mRNA at 24 h post flagellin stimulation
relative to both non-transfected and scrambled siRNA
controls (p < 0.001, Figure 4B). The third siRNA had no
Figure 3 Analysis of bovine TLR5 activity in bovine epithelial cells. The bovine EBL cell line was stably transfected with a bTLR5 clone and
CXCL8 secretion assayed following challenge with flagellin. (A) CXCL8 levels from EBLs with and without transfection of bTLR5. H7 flagellin at a
range of concentrations was added to the cells and CXCL8 levels were measured by ELISA following overnight incubation. Transfection with
bTLR5 resulted in significantly higher levels of CXCL8 being produced by the bTLR5+ cells with addition of 50-50 000 ng/mL of H7 flagellin
(p < 0.001). The data shown are the means and 95% confidence intervals. (B) Analysis of CXCL8 production from EBL-TLR5 in response to addition
of native H7 or an H7 flagellin preparation from which the majority of LPS has been removed. Medians and interquartile ranges are shown.
(C) Secreted CXCL8 following addition of WT and mutated H7 flagellins to EBLs with transfected bTLR5. 50 ng/mL of WT-H7 and mutated flagellins
were added to the EBLs transfected with bTLR5 and incubated overnight. CXCL8 was measured by ELISA. Addition of the R90T, R90A and L500A/I504A
variants led to significantly lower levels of cytokine release (p < 0.001) relative to WT-H7 stimulation (asterisks). R90T showed a significantly lower
induction than R90A (p < 0.001). Medians and interquartile ranges are shown. (D) Secreted CXCL8 following addition of WT H7 and the R90T flagellin
mutant to EBL cells. A range of flagellin concentrations was incubated overnight with the cells and CXCL8 measured by ELISA. R90T flagellin demonstrated
significantly reduced levels of CXCL8 activation at 50 ng/mL and 500 ng/mL (p < 0.001), marked by asterisks. The data shown are the means and 95%
confidence intervals. All CXCL8 data shown is from a minimum of three biological replicates.
Tahoun et al. Veterinary Research  (2015) 46:9 Page 10 of 15effect and is not shown. CXCL8 mRNA levels (Figure 4C)
were reduced at 24 h post flagellin addition for the cells
transfected with siRNAs #2 & #3 relative to the controls
(p < 0.05) and this correlated with a significant reduction
in secreted CXCL8 for siRNA #2 at 24 h (p = 0.012) and
for siRNA #3 at 24 h (p < 0.001) relative to controls
(Figure 4D). Bovine MDMs treated with siRNA #3 pro-
duced less CXCL8 in response to crude LPS activation
than measured in siRNA #2-treated and control MDMs
(data not shown), suggesting another effect of this
siRNA on bovine MDM function or viability. This may
explain the enhanced effect of siRNA #3 compared to
siRNA #2 with respect to CXCL8 mRNA expression and
protein secretion. Taken together, these data indicate apositive association of TLR5 expression in bovine
MDMs with both CXCL8 mRNA expression and CXCL8
secreted cytokine production in response to addition of
H7 flagellin.
To determine if a variant flagellin with reduced TLR5
activation (relative to WT-H7) also had a reduced cap-
acity to stimulate CXCL8 when added to the bovine
MDMs, the R90T flagellin was tested. While addition of
50 ng/mL R90T produced significantly lower levels of
secreted CXCL8 compared to addition of WT H7 (p =
0.02, Figure 4E), this reduction in secreted CXCL8 levels
was only 50% compared to the >10 fold difference dem-
onstrated for the same variant on EBLs expressing
bTLR5 (Figure 3C).
Figure 4 Responses of bovine monocyte-derived macrophages (bMDMs) to flagellin. (A) mRNA levels of CXCL8 and TLR5 following
addition of flagellin to bMDMs. Transcript levels are plotted relative to time 0 and increase significantly at 4 h and 24 h (p < 0.001), while TLR5
transcript levels are lower (p < 0.001) 4 h after addition of flagellin but not significantly different (p = 0.073) at 24 h, significance marked by
asterisks. (B) Assessment of TLR5 transcript levels in bMDMs. Transfected cells were pre-incubated with siRNAs for 48 h then WT H7 flagellin
(26.5 ng/mL) added (time 0). TLR5 transcripts were reduced by treatment with both TLR5#2 and TLR5#3 relative to controls at both time 0 and
24 h (p < 0.001), marked by asterisks. (C) Assessment of CXCL8 transcript levels in bMDMs. CXCL8 mRNA levels were measured in cells challenged
with WT H7 flagellin as above. CXCL8 transcript levels were significantly reduced in the cells treated with the TLR5#2 and TLR5#3 siRNAs relative
to the controls at 24 h (p < 0.001), indicated by asterisks. Data is from three biological repeats with a minimum of three technical replicates.
(D) Determination of released CXCL8 from bMDMs with reduced TLR5 expression. bMDMs were treated as above and supernatant CXCL8
determined by ELISA. TLR5 #3 siRNA significantly reduced secreted levels of CXCL8 relative to un-transfected controls at 24 h (p < 0.001), while a
significant reduction was evident for TLR5 #2 at 24 h (p = 0.012), marked with asterisks. (E) CXCL8 release from bMDMs challenged with WT and
altered H7 flagellin. CXCL8 was measured in the supernatants of the bMDMs 24 h after stimulation with WT or R90T H7 flagellin. The CXCL8 levels
released were significantly lower for R90T compared with WT flagellin (p = 0.022, asterisk). All plots show medians with upper and lower quartiles;
outliers as dark circles.
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immunization with WT-H7 flagella and R90T derivative
Two groups of male Holstein-Friesian calves (n = 6) were
immunized twice with an interval of two weeks (day 0
and day 14) with either WT-H7 plus Quil A adjuvant or
R90T-H7 plus Quil A adjuvant. A further group of three
calves were immunized with adjuvant only. The LPS
levels in the two flagellin preparations were equivalent
(Materials and Methods). Serum IgA titres against both
LPS-free (<0.05 EU per μg protein) WT-H7 and R90T-
H7 were determined by end-point ELISA until two weeks
after the second immunization (Figure 5). Immunization
with both WT-H7 and R90T-H7 resulted in significant in-
creases in serum IgA antibodies against WT-H7 from 7
days after the first immunization and these remained ele-
vated until two weeks after the second immunization by
comparison to serum from animals immunized with adju-
vant only (Figure 5, p < 0.01). The same pattern was ob-
served when IgA responses were analysed with plates
coated with R90T-H7 indicating that the amino acid
change was unlikely to have altered overall presentation of
the flagellin and epitopes (data not shown). There was no
significant difference in IgA levels produced between the
groups immunized with WT-H7 and R90T-H7, although
median levels of IgA from the animals immunized with
WT-H7 were consistently higher than those receiving
R90T-H7 (Figure 5A). The variation between samples and
low animal numbers means that the study was underpow-
ered to detect relatively subtle differences in IgA titres.
Combining the T2-T4 IgA responses for the two groups
approaches significance (p = 0.07) in terms of a reduced
IgA response for the animals immunized with R90T.Figure 5 IgA responses of cattle immunized with WT and R90T H7 flage
route 2 weeks apart with either 60 μg of WT H7 flagellin + 5mg Quil A (n = 6),
(n = 3) as described in the Materials and methods. Levels of anti WT-H7 specif
times indicated. Animals were immunized at day 0 and day 14. Plots show th
of the three groups. The sampling times were a day before immunization, and
to ease visualization.Discussion
There is considerable interest in using factors that
stimulate pattern recognition receptors (PRRs) as adju-
vants. MAMPs are a logical inclusion in vaccine formu-
lations as they stimulate the natural recognition systems
allied to host innate and adaptive responses [35,36]. Fla-
gellin monomers are powerful agonists through TLR5
activation as demonstrated in mice and humans [20,37]
but their potency to activate TLR5 in cattle is unclear.
Our work is focused on responses stimulated by H7 flagel-
lin in cattle for two reasons: (1) generically, as an adjuvant
that can stimulate mucosal responses in ruminants; (2) as
an antigen to limit EHEC O157:H7 colonisation following
vaccination in the reservoir host. Our previous research
has demonstrated that systemic immunization with H7
flagella can limit EHEC O157:H7 colonisation possibly by
eliciting specific IgA response and high IgG titres [3,8].
The nature of this response was in line with recent find-
ings in mice that have shown the importance of TLR5 in
mediating an IgA response to flagellins following systemic
injection [20]. However, the responses in cattle were coun-
ter to a recent report that indicated minimal activity of
cells containing a bovine TLR5 clone [24]. The purpose of
the current study was therefore to investigate the func-
tionality of bovine TLR5 using a combination of in vitro
and in vivo approaches.
The research presented provides evidence that bovine
TLR5 (EMBL ABC68311.1) is functional in terms of fla-
gellin recognition and signalling. The TLR5 clone sig-
nalled through an NFkB reporter when transfected into
HEK293 cells; the signalling was reduced when specific
mutations were introduced into the H7 flagellin TLR5-llin. Three groups of calves were immunized twice via the intramuscular
60 μg of R90T H7 flagellin + 5mg Quil A (n = 6) or 5mg Quil A alone
ic IgA were determined by end-point ELISA from serum sampled at the
e log2 transformed endpoint titre values for each animal sample for each
days, 8, 22 and 28 post-immunization; the groups have been separated
Tahoun et al. Veterinary Research  (2015) 46:9 Page 13 of 15binding domain. It was apparent that the human clone
used in our study did activate the NK-kB reporter to
higher levels than the bovine clone in the HEK293 back-
ground, at least at when the cells were challenged with
lower levels of H7 flagellin. We do not know whether
this is due to differences in expression levels of the dif-
ferent TLR5s, and/or signalling activity. Recently re-
ported research on bovine TLR5 by Metcalfe et al. [24]
provided no evidence of bTLR signalling in HEK293T
cells and we reasoned that this may be due to: (1) either
very low levels of transfection and a different reporter
system in their study; (2) differences in signalling in the
HEK293 and HEK293T cells based on residual human
TLR activity. We have found positively selected codons
in the bovine TIR domain which may alter its interac-
tions with MyD88 and other signalling molecules and
impact on signalling in cells of different animal origin
[22]. To ensure compatibility, we tested the bovine
TLR5 clone in a bovine cell line. Prior to transfection,
the bovine epithelial cell line, EBL, showed no produc-
tion of IL8/CXCL8 when flagellin was added. This cell
line was then transfected with a bTLR5 sub-clone gener-
ated in this study and this resulted in cells that secreted
CXCL8 in response to addition of flagella in a dose-
dependent manner. This secretion was reduced when
the mutated H7 flagellin R90T was added. While this
data indicated that the bTLR5 clone is active in response
to flagellin in a bovine cell background, further work is
required to assess which cells and tissues express TLR5
in cattle. It was interesting that un-transfected EBL cells
did not express a TLR5 transcript (data not shown) and
were not activated by addition of H7 flagellin; this is in
line with reports that udder tissue does not express
TLR5 [38] and both bovine primary colonocyte cultures
and bovine neutrophils were negative for TLR5 expres-
sion [39,40]. A key restriction for future work on cell-
and tissue-specific expression is the development of
reagents that recognise ruminant TLR5, particularly in
its native conformation.
Based on current research, the key cells involved in
stimulating host responses to flagellins are most likely
specific subsets of dendritic cells and/or macrophages
[20,21]. We therefore wanted to analyse TLR5-dependent
responses to H7 flagellin by bovine macrophages. Macro-
phages were derived from blood monocytes [29] for which
RNA silencing methods have been developed [28]. These
cells showed detectable expression of TLR5 mRNA which
could be knocked down by various TLR5 specific siRNAs.
These cells produced CXCL8 mRNA and cytokine in re-
sponse to flagella and this response was restricted by the
anti-TLR5 siRNAs. It was interesting that the level of
TLR5 mRNA reduced significantly 4 h following addition
of flagellin, indicating that recognition of the agonist leads
to a regulatory shift in the sensing cells. However, thisimmediate repression appeared to be temporary as the
TLR5 transcript levels were similar to the initial levels at
24 h, perhaps indicating some type of homeostatic re-
sponse to continuous flagellin activation. While this study
did demonstrate functional TLR5-dependent signalling by
bovine macrophages it was evident from the TLR5 knock-
downs and studies with the mutated flagellins that other
TLR5-independent responses to the flagellins were occur-
ring which did not appear to be the case for the transfected
EBL cells. It has been shown that flagellin recognition
can also be mediated through cytosolic NAIP and
NLRC4-dependent inflammasomes [41,42]. Thus bovine
macrophages, unlike bovine EBLs, presumably internalise
flagellin into the cytosol, leading to activation of inflam-
masomes, but further research is required to confirm if
this is the case and the consequences of this activation.
To test whether the reduced capacity to stimulate
bTLR5 in vitro might alter the humoral IgA response to
flagellin, cattle were immunized with either WT-H7 or
R90T-H7 flagellin preparations. IgA responses in cattle
serum to both flagellins were determined by end-point
titration ELISAs. Immunization with the R90T led to
levels of serum IgA that were consistently lower than
those detected for the WT-H7 irrespective of the coated
flagellin antigen used in the ELISA (WT or R90T). How-
ever, these differences were not significant (P > 0.05) as a
consequence of high titre variation between animals and
the relatively small numbers of calves in each group
(n = 6). The finding that the variant R90T-H7 was also
able to stimulate IgA responses was perhaps not surprising
given that this variant was still able to activate bTLR5 sig-
nalling, although at a reduced level compared to WT-H7.
Differences in vitro were dependent on the amount of fla-
gellin used and how these levels translate to the sensitivity
in vivo is unknown. Furthermore the difference in terms
of CXCL8 secretion from bovine MDMs stimulated with
WT-H7 vs R90T-H7, while significantly reduced for the
variant, was less than two-fold at the concentration exam-
ined (Figure 4E). As discussed above, it is possible that
other TLR5-independent signalling pathways may contrib-
ute to the IgA response in cattle following systemic
immunization with flagellin. Another consideration for
the cattle immunizations experiments is that QuilA was
used as an adjuvant and immune stimulating complexes
(ISCOMS) containing Quil A can help induce IgA re-
sponses when delivered mucosally. However, we are aware
from our previous work examining systemic delivery of
antigens other than flagellin that Quil A does not usually
induce IgA responses to these [8,9]. So while we appreci-
ate there may well be synergy between the adjuvants,
QuilA and flagellin, flagellin is required for overt IgA
responses.
Proof of TLR5-dependent IgA production in cattle
would ideally require cattle that do not express functional
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present in cattle with stop codons in the ectodomain
which are likely to impair function [22]. However their fre-
quencies would indicate that where present, they would
probably be heterozygous. Nonetheless a different stop
codon mutation in human TLR5 is a dominant negative
mutation and its presence as a heterozygote in humans
leads to significantly lower natural levels of flagellin-
specific IgG and IgA [43]. Thus it may be possible to in-
vestigate whether cattle carrying the STOP codon mutants
respond less well to systemic immunisation with H7 fla-
gellin. It may also be possible to identify bovine sires car-
rying these STOP codons and select homozygotes which
would be TLR5 negative, allowing more definitive experi-
ments on the role of bovine TLR5 in vivo.
The TIR domain is important for signal transduction
for TLR5, although less is known about the TLR5 signal-
ing motifs and pathways for other TLRs. It is intriguing
that the bTLR5 is functional given that it possesses a
Y798P change compared to other mammalian TLR5 se-
quences and that Y798L has been shown to negate TLR5
signalling activity in mice [23]. However, the serine at
position 805 may also be critical for signalling [44], and
this is present in the WT bovine TLR5. Evidence sug-
gests that ruminant TLR5 has undergone adaptive evolu-
tion which is still ongoing as SNPs were co-localised
with predicted adaptive codons [22]. This would suggest
that the interactions between flagellins and bovine TLR5
are drivers of evolutionary changes which may have
functional consequences in terms of both infectious dis-
ease susceptibility and/or inflammatory disorders as de-
scribed for humans [43,45]. On-going work is investigating
the critical residues required for bTLR5 responses and the
pathways induced by flagellin recognition. Potentially
polymorphisms might account for variation seen in the re-
sponses in the flagellin immunisation experiments carried
out in the present animal study.
Flores-Langarica et al. [20] have shown in mice that
CD103+ TLR5+ dendritic cell numbers drop in the lam-
ina propria following systemic immunization with flagel-
lins, and that this reduction is associated with an
increase in these cells within the local mesenteric lymph
nodes. They conclude that this subset of cells traffics to
the local node following TLR5-dependent flagellin stimu-
lation to present flagellin peptides to T cells and promote
class switching of flagellin-specific B cells to IgA. It has
been also been shown that humoral immunity in response
to flagellin can depend on other TLR5 independent path-
ways which involve NAIPs and NLRC4 inflammasome ac-
tivation [27] and/or a novel MyD88 independent pathway
[46]. Their relevance for cattle is unknown at present. A
logical progression of the work in this area is to obtain
similar mucosal responses to systemically delivered heter-
ologous antigens expressed either within or conjugated toflagellins. Future work will test immune responses in cattle
induced by heterologous flagellin-antigen constructs, as
well as defining the specificity of bovine TLR5 stimulation
by different flagellin sequences to determine the most ap-
propriate flagellin constructs for use as an adjuvant in this
species.
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